JANE STREET GROUP, LLC - AMPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$19,000
-17.4%
318,836
+133.6%
0.00%
Q2 2022$23,000
-23.3%
136,486
+645.6%
0.00%
Q3 2021$30,000
-91.1%
18,306
-90.9%
0.00%
Q2 2021$336,000
+1192.3%
201,567
+1207.2%
0.00%
Q1 2021$26,000
-82.6%
15,420
-83.5%
0.00%
Q4 2020$149,000
+1555.6%
93,451
+318.6%
0.00%
Q1 2020$9,000
-94.6%
22,322
-94.8%
0.00%
Q2 2019$166,000
+621.7%
426,932
+858.3%
0.00%
Q3 2018$23,000
-55.8%
44,553
+193.1%
0.00%
Q1 2018$52,000
-48.5%
15,200
-64.3%
0.00%
-100.0%
Q2 2015$101,00042,5660.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders